Identifying potential alternative medications, assessment of pancreatitis risk factors, and careful monitoring, are all important tenets in addressing GLP-1 agonists and pancreatitis
Still, it affects several markers clinicians rely on, including blood sugar, HbA1c, insulin levels, and, in some cases, lipids or liver enzymes, during active weight loss
doi: Jastreboff AM, Aronne LJ, Ahmad NN, et al
Cardiovascular and Endothelial Benefits GLP-1 RAs have demonstrated robust cardiovascular protection in multiple large-scale trials, including LEADER, REWIND, and SUSTAIN-6, showing reduced rates of major adverse cardiac events independent of weight loss
Support groups, where folks exchange advice or discuss challenges, may assist